Back to Search Start Over

Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: Accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model.

Authors :
Chien, Yueh
Chang, Yuh-Lih
Li, Hsin-Yang
Larsson, Mikael
Wu, Wai-Wah
Chien, Chian-Shiu
Wang, Chien-Ying
Chu, Pen-Yuan
Chen, Kuan-Hsuan
Lo, Wen-Liang
Chiou, Shih-Hwa
Lan, Yuan-Tzu
Huo, Teh-Ia
Lee, Shou-Dong
Huang, Pin-I
Source :
Acta Biomaterialia; Feb2015, Vol. 13, p228-244, 17p
Publication Year :
2015

Abstract

MicroRNA122 (miR122), a liver-specific microRNA, plays critical roles in homeostatic regulation and hepatic-specific differentiation. Induced pluripotent stem cells (iPSCs) have promising potential in regenerative medicine, but it remains unknown whether non-viral vector-mediated miR122 delivery can enhance the differentiation of iPSCs into hepatocyte-like cells (iPSC-Heps) and rescue thioacetamide-induced acute hepatic failure (AHF) in vivo. In this study, we demonstrated that embedment of miR122 complexed with polyurethane-graft-short-branch polyethylenimine copolymer (PU-PEI) in nanostructured amphiphatic carboxymethyl–hexanoyl chitosan (CHC) led to dramatically enhanced miR122 delivery into human dental pulp-derived iPSCs (DP-iPSCs) and facilitated these DP-iPSCs to differentiate into iPSC-Heps (miR122-iPSC-Heps) with mature hepatocyte functions. Microarray and bioinformatics analysis further indicated that CHC/PU-PEI-miR122 promoted the gene-signature pattern of DP-iPSCs to shift into a liver-specific pattern. Furthermore, intrahepatic delivery of miR122-iPSC-Heps, but not miR-Scr-iPSC-Heps, improved liver functions and rescued recipient survival, and CHC-mediated delivery showed a better efficacy than that using phosphate buffered saline as a delivery vehicle. In addition, these transplanted miR122-iPSC-Heps remained viable and could produce circulatory albumin for 4 months. Taken together, our findings demonstrate that non-viral delivery of miR122 shortens the time of iPSC differentiation into hepatocytes and the delivery of miR122-iPSC-Heps using CHC as a vehicle exhibited promising hepatoprotective efficacy in vivo. miR122-iPSC-Heps may represent a feasible cell source and provide an efficient and alternative strategy for hepatic regeneration in AHF. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17427061
Volume :
13
Database :
Supplemental Index
Journal :
Acta Biomaterialia
Publication Type :
Academic Journal
Accession number :
100362190
Full Text :
https://doi.org/10.1016/j.actbio.2014.11.018